재택 약물 남용 검사 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 샘플 유형별, 제품 유형별, 지역별, 경쟁별(2020-2030년)

Global At-Home Drug of Abuse Testing Market was valued at USD 675.95 million in 2024 and is expected to experience strong growth during the forecast period, with a compound annual growth rate (CAGR) of 5.01% through 2030. The market is expanding rapidly, driven by increasing awareness of substance abuse, ongoing advancements in testing technologies, and a growing demand for discreet, at-home screening options. These self-administered test kits offer users a private and convenient method to monitor drug use, eliminating the need for clinical visits. The demand for such solutions is particularly strong among individuals who value confidentiality in drug testing.

Despite the market's positive growth trajectory, concerns about the accuracy and reliability of at-home testing kits remain. Issues such as variations in testing methods, improper sample collection, and limited detection capabilities can result in inconsistent test results, leading to false positives or negatives. These inaccuracies can have serious consequences, especially for individuals undergoing rehabilitation or involved in legal proceedings. In response, manufacturers are focusing on enhancing test precision, improving sample collection processes, and expanding the range of detectable substances to enhance the credibility and usefulness of at-home DOA testing.

Key Market Drivers:

Prevalence of Substance Abuse: The widespread misuse of illicit and prescription drugs has created an increasing demand for frequent drug testing. In 2021, approximately 1 in 17 individuals aged 15-64 globally reported using a drug in the past year. The number of drug users rose from 240 million in 2011 to 296 million in 2021, accounting for 5.8% of the global population in this age group-a 23% increase. This trend has been driven in part by population growth and changing substance use patterns. The opioid crisis, particularly in North America, along with the growing legalization of cannabis in various regions, has raised concerns regarding workplace productivity, driving safety, and adolescent health. Additionally, the rising consumption of synthetic drugs, including methamphetamines and fentanyl analogs, has created a pressing need for cost-effective and rapid drug testing solutions. As a result, consumers and organizations are increasingly turning to at-home drug testing kits to identify substance use early and inform intervention or treatment decisions.

Key Market Challenges:

Accuracy and Reliability: Inaccurate test results, including false positives (indicating drug use when there is none) and false negatives (failing to detect drug use), can have significant consequences. These errors may lead to unnecessary panic or complacency, potentially undermining the credibility of at-home testing kits. If these tests are perceived as unreliable, consumers may lose confidence in the results, leading to reduced adoption rates. Inaccurate results can also influence critical decisions, such as treatment options or behavior changes, and may negatively impact legal cases or employment decisions. Unreliable test results can also harm the reputation of specific brands or the broader at-home drug testing market, resulting in negative word-of-mouth and potentially leading to stricter regulatory scrutiny. Ensuring consistent accuracy across various brands and batches presents an ongoing challenge for manufacturers, with quality control issues potentially affecting consumer perception.

Key Market Trends:

Advancements in Multi-Panel Testing Kits: Multi-panel testing kits, which detect multiple substances in a single test, are gaining traction due to their convenience and cost-effectiveness. By allowing users to screen for multiple drugs at once, these kits save time and reduce the need for separate tests. This efficiency is encouraging broader adoption and market growth. Moreover, multi-panel kits are often more affordable than purchasing individual tests for each drug, further boosting their popularity. These kits cover a wider range of substances, including common drugs of abuse and emerging drugs, thus meeting the diverse needs of users. They are especially appealing to parents concerned about their children's potential drug use, as well as to legal and clinical professionals who require more comprehensive information to make informed decisions. Public health campaigns promoting comprehensive drug testing align with the growing trend of multi-panel kits, further contributing to their widespread adoption.

Key Market Players

• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA.
• UCP Biosciences Inc.
• Orient New Life Medical Co. Ltd.
• Assure Tech. (Hangzhou) Co., LTD
• Psychemedics Corporation
• Confirm Biosciences Inc
• Pharmatech Inc.
• Atlas Medical GmbH
• Home Health (U.K.) Ltd

Report Scope:

In this report, the Global At-Home Drug of Abuse Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

At-Home Drug of Abuse Testing Market, By Sample Type:

• Urine Test
• Saliva Test
• Blood test
• Others

At-Home Drug of Abuse Testing Market, By Product Type:

• Drug Testing Kit
• Strips/Dip Cards
• Cassettes
• Cups
• Others

At-Home Drug of Abuse Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global At-Home Drug of Abuse Testing Market.

Available Customizations:

Global At-Home Drug of Abuse Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global At-Home Drug of Abuse Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 5.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Sample Type
• 5.3.2 By Product Type
• 5.3.3 By Region

6. North America At-Home Drug of Abuse Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 6.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States At-Home Drug of Abuse Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Sample Type
      • 6.3.1.2.2. By Product Type
  • 6.3.2. Canada At-Home Drug of Abuse Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Sample Type
      • 6.3.2.2.2. By Product Type
  • 6.3.3. Mexico At-Home Drug of Abuse Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Sample Type
      • 6.3.3.2.2. By Product Type

7. Europe At-Home Drug of Abuse Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 7.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France At-Home Drug of Abuse Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Sample Type
      • 7.3.1.2.2. By Product Type
  • 7.3.2. Germany At-Home Drug of Abuse Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Sample Type
      • 7.3.2.2.2. By Product Type
  • 7.3.3. United Kingdom At-Home Drug of Abuse Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Sample Type
      • 7.3.3.2.2. By Product Type
  • 7.3.4. Italy At-Home Drug of Abuse Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Sample Type
      • 7.3.4.2.2. By Product Type
  • 7.3.5. Spain At-Home Drug of Abuse Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Sample Type
      • 7.3.5.2.2. By Product Type

8. Asia-Pacific At-Home Drug of Abuse Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 8.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China At-Home Drug of Abuse Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Sample Type
      • 8.3.1.2.2. By Product Type
  • 8.3.2. India At-Home Drug of Abuse Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Sample Type
      • 8.3.2.2.2. By Product Type
  • 8.3.3. Japan At-Home Drug of Abuse Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Sample Type
      • 8.3.3.2.2. By Product Type
  • 8.3.4. South Korea At-Home Drug of Abuse Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Sample Type
      • 8.3.4.2.2. By Product Type
  • 8.3.5. Australia At-Home Drug of Abuse Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Sample Type
      • 8.3.5.2.2. By Product Type

9. South America At-Home Drug of Abuse Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 9.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil At-Home Drug of Abuse Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Sample Type
      • 9.3.1.2.2. By Product Type
  • 9.3.2. Argentina At-Home Drug of Abuse Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Sample Type
      • 9.3.2.2.2. By Product Type
  • 9.3.3. Colombia At-Home Drug of Abuse Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Sample Type
      • 9.3.3.2.2. By Product Type

10. Middle East and Africa At-Home Drug of Abuse Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 10.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa At-Home Drug of Abuse Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Sample Type
      • 10.3.1.2.2. By Product Type
  • 10.3.2. Saudi Arabia At-Home Drug of Abuse Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Sample Type
      • 10.3.2.2.2. By Product Type
  • 10.3.3. UAE At-Home Drug of Abuse Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Sample Type
      • 10.3.3.2.2. By Product Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global At-Home Drug of Abuse Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Dragerwerk AG & Co. KGaA.
• 15.3. UCP Biosciences Inc.
• 15.4. Orient New Life Medical Co. Ltd.
• 15.5. Assure Tech. (Hangzhou) Co., LTD
• 15.6. Psychemedics Corporation
• 15.7. Confirm Biosciences Inc
• 15.8. Pharmatech Inc.
• 15.9. Atlas Medical GmbH
• 15.10. Home Health (U.K.) Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer